Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa.
Journal
The British journal of dermatology
ISSN: 1365-2133
Titre abrégé: Br J Dermatol
Pays: England
ID NLM: 0004041
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
accepted:
30
12
2020
pubmed:
6
1
2021
medline:
27
7
2021
entrez:
5
1
2021
Statut:
ppublish
Résumé
Hidradenitis suppurativa (HS) is a chronic inflammatory disease, characterized by painful, purulent and destructive skin alterations in intertriginous areas. We investigated the expression and role in HS of granulocyte colony-stimulating factor (G-CSF), the regulator of neutrophil biology, as clinical signs of a neutrophilic granulocyte-driven inflammation are distinctive in the disease. Skin and blood samples obtained from different cohorts of patients with HS and control individuals were assessed by RNA sequencing, quantitative polymerase chain reaction on reverse transcribed mRNA, and/or enzyme-linked immunosorbent assay. Mechanistic studies using keratinocytes, dermal fibroblasts, immune cell populations and skin biopsies were performed. G-CSF was abundant in HS skin, particularly in inflamed nodules and abscesses. Its levels even exceeded those found in other inflammatory skin diseases. Interleukin (IL)-1 and IL-17, respectively, induced G-CSF production by fibroblasts and keratinocytes. These effects were enhanced by tumour necrosis factor (TNF)-α and IL-36. Accordingly, fibroblasts separated from HS lesions expressed G-CSF, and IL-1 receptor antagonist reduced G-CSF levels in explanted HS skin. G-CSF blood levels positively correlated with severity of HS. Elevated lesional G-CSF receptor levels were linked to upregulation of molecules that contribute to prolonged activation of neutrophils by components of bacteria and damaged host cells [formyl peptide receptor 1 (FPR1), FPR2 and free fatty acid receptor 2 (FFAR2)], neutrophil survival [TNF receptor superfamily member 10C (TNFRSF10C/TRAIL-R3) and TNF receptor superfamily member 6B], kinases (tyrosine-protein kinase HCK and hexokinase 3), and skin destruction [MMP25 (matrix metalloproteinase 25) and ADAM8 (disintegrin and metalloproteinase domain-containing protein 8)]. G-CSF elevated the expression of FPR1, FFAR2, and TNFRSF10C/TRAIL-R3 in neutrophils and synergized with bacterial components to induce skin-destructive enzymes. The G-CSF pathway engages both tissue and immune cells, is strongly activated in HS lesions, and offers the opportunity to target the neutrophil-driven inflammation.
Sections du résumé
BACKGROUND
Hidradenitis suppurativa (HS) is a chronic inflammatory disease, characterized by painful, purulent and destructive skin alterations in intertriginous areas.
OBJECTIVES
We investigated the expression and role in HS of granulocyte colony-stimulating factor (G-CSF), the regulator of neutrophil biology, as clinical signs of a neutrophilic granulocyte-driven inflammation are distinctive in the disease.
METHODS
Skin and blood samples obtained from different cohorts of patients with HS and control individuals were assessed by RNA sequencing, quantitative polymerase chain reaction on reverse transcribed mRNA, and/or enzyme-linked immunosorbent assay. Mechanistic studies using keratinocytes, dermal fibroblasts, immune cell populations and skin biopsies were performed.
RESULTS
G-CSF was abundant in HS skin, particularly in inflamed nodules and abscesses. Its levels even exceeded those found in other inflammatory skin diseases. Interleukin (IL)-1 and IL-17, respectively, induced G-CSF production by fibroblasts and keratinocytes. These effects were enhanced by tumour necrosis factor (TNF)-α and IL-36. Accordingly, fibroblasts separated from HS lesions expressed G-CSF, and IL-1 receptor antagonist reduced G-CSF levels in explanted HS skin. G-CSF blood levels positively correlated with severity of HS. Elevated lesional G-CSF receptor levels were linked to upregulation of molecules that contribute to prolonged activation of neutrophils by components of bacteria and damaged host cells [formyl peptide receptor 1 (FPR1), FPR2 and free fatty acid receptor 2 (FFAR2)], neutrophil survival [TNF receptor superfamily member 10C (TNFRSF10C/TRAIL-R3) and TNF receptor superfamily member 6B], kinases (tyrosine-protein kinase HCK and hexokinase 3), and skin destruction [MMP25 (matrix metalloproteinase 25) and ADAM8 (disintegrin and metalloproteinase domain-containing protein 8)]. G-CSF elevated the expression of FPR1, FFAR2, and TNFRSF10C/TRAIL-R3 in neutrophils and synergized with bacterial components to induce skin-destructive enzymes.
CONCLUSIONS
The G-CSF pathway engages both tissue and immune cells, is strongly activated in HS lesions, and offers the opportunity to target the neutrophil-driven inflammation.
Substances chimiques
Membrane Proteins
0
Tumor Necrosis Factor-alpha
0
Granulocyte Colony-Stimulating Factor
143011-72-7
ADAM Proteins
EC 3.4.24.-
ADAM8 protein, human
EC 3.4.24.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
164-176Subventions
Organisme : Sanofi-Aventis Deutschland GmbH
ID : AVD 123938
Organisme : German Federal Ministry of Education and Research
ID : 01ZX1312A
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2021 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Références
Sabat R, Jemec GBE, Matusiak L et al. Hidradenitis suppurativa. Nat Rev Dis Primers 2020; 6:18.
Ingram JR, Jenkins-Jones S, Knipe DW et al. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol 2018; 178:917-24.
Calao M, Wilson JL, Spelman L et al. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: a population-based cross-sectional study. PLoS One 2018; 13:e0200683.
Matusiak L, Szczech J, Kaaz K et al. Clinical characteristics of pruritus and pain in patients with hidradenitis suppurativa. Acta Derm Venereol 2018; 98:191-4.
Alavi A, Farzanfar D, Lee RK, Almutairi D. The contribution of malodour in quality of life of patients with hidradenitis suppurativa. J Cutan Med Surg 2018; 22:166-74.
Nielsen RM, Lindso Andersen P, Sigsgaard V et al. Pain perception in patients with hidradenitis suppurativa. Br J Dermatol 2020; 182:166-74.
Matusiak L, Bieniek A, Szepietowski JC. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol 2010; 90:264-8.
Kurek A, Peters EMJ, Sabat R et al. Depression is a frequent co-morbidity in patients with acne inversa. J Dtsch Dermatol Ges 2013; 11:743-9, 743-50 (in German).
Shavit E, Dreiher J, Freud T et al. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2015; 29:371-6.
Kurek A, Peters EM, Chanwangpong A et al. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol 2012; 67:422-8, 428.e421.
Schneider-Burrus S, Jost A, Peters EMJ et al. Association of hidradenitis suppurativa with body image. JAMA Dermatol 2018; 154:447-51.
Kaaz K, Szepietowski JC, Matusiak L. Sleep quality among adult patients with chronic dermatoses. Postepy Dermatol Alergol 2019; 36:659-66.
Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010; 62:706-8, 708.e701.
Sandhu VK, Shah M, Piguet V, Alavi A. The impact of hidradenitis suppurativa on work productivity and activity impairment. Br J Dermatol 2020; 182:1288-90.
Wlodarek K, Glowaczewska A, Matusiak L, Szepietowski JC. Psychosocial burden of hidradenitis suppurativa patients’ partners. J Eur Acad Dermatol Venereol 2020; 34:1822-7.
Tiri H, Jokelainen J, Timonen M et al. Substantially reduced life expectancy in patients with hidradenitis suppurativa: a Finnish nationwide registry study. Br J Dermatol 2019; 180:1543-4.
Sabat R, Chanwangpong A, Schneider-Burrus S et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 2012; 7:e31810.
Gonzalez-López MA, Hernández JL, Lacalle M et al. Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol 2016; 75:329-35.
Richette P, Molto A, Viguier M et al. Hidradenitis suppurativa associated with spondyloarthritis - results from a multicenter national prospective study. J Rheumatol 2014; 41:490-4.
Schneider-Burrus S, Witte-Haendel E, Christou D et al. High prevalence of back pain and axial spondyloarthropathy in patients with hidradenitis suppurativa. Dermatology 2016; 232:606-12.
Deckers IE, Benhadou F, Koldijk MJ et al. Inflammatory bowel disease is associated with hidradenitis suppurativa: results from a multicenter cross-sectional study. J Am Acad Dermatol 2017; 76:49-53.
Egeberg A, Jemec GBE, Kimball AB et al. Prevalence and risk of inflammatory bowel disease in patients with hidradenitis suppurativa. J Invest Dermatol 2017; 137:1060-4.
Zouboulis CC, Okun MM, Prens EP et al. Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study. J Am Acad Dermatol 2019; 80:60-69.e2.
Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020; 183:999-1010.
Wolk K, Warszawska K, Hoeflich C et al. Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 2011; 186:1228-39.
Kelly G, Hughes R, McGarry T et al. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Br J Dermatol 2015; 173:1431-9.
Scala E, Di Caprio R, Cacciapuoti S et al. A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26. Br J Dermatol 2019; 181:1038-45.
Thomi R, Kakeda M, Yawalkar N et al. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2017; 31:2091-6.
Di Caprio R, Balato A, Caiazzo G et al. IL-36 cytokines are increased in acne and hidradenitis suppurativa. Arch Dermatol Res 2017; 309:673-8.
Hessam S, Sand M, Gambichler T et al. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop. Br J Dermatol 2018; 178:761-7.
Witte-Händel E, Wolk K, Tsaousi A et al. The IL-1 pathway is hyperactive in hidradenitis suppurativa and contributes to skin infiltration and destruction. J Invest Dermatol 2019; 139:1294-305.
Witte E, Kokolakis G, Witte K et al. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med (Berl) 2016; 94:391-400.
Wolk K, Frambach Y, Jacobi A et al. Increased levels of lipocalin 2 in palmoplantar pustular psoriasis. J Dermatol Sci 2018; 90:68-74.
Wolk K, Kunz S, Witte E et al. IL-22 increases the innate immunity of tissues. Immunity 2004; 21:241-54.
Martin JC, Wolk K, Bériou G et al. Limited presence of IL-22 binding protein, a natural IL-22 inhibitor, strengthens psoriatic skin inflammation. J Immunol 2017; 198:3671-8.
Tsaousi A, Witte E, Witte K et al. MMP8 is increased in lesions and blood of acne inversa patients: a potential link to skin destruction and metabolic alterations. Mediators Inflamm 2016; 2016:4097574.
Matusiak L, Szczęch J, Bieniek A et al. Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol 2017; 76:670-5.
Wolk K, Wenzel J, Tsaousi A et al. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. Br J Dermatol 2017; 177:1385-93.
Bendall LJ, Bradstock KF. G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev 2014; 25:355-67.
Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov 2020; 19:253-75.
Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. J Leukoc Biol 2020; 108:377-96.
Colotta F, Re F, Polentarutti N et al. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80:2012-20.
Gregory AD, Hogue LA, Ferkol TW et al. Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection. Blood 2007; 109:3235-43.
Grandemange S, Aksentijevich I, Jeru I et al. The regulation of MEFV expression and its role in health and familial Mediterranean fever. Genes Immun 2011; 12:497-503.
Sabat R, Wolk K, Loyal L et al. T cell pathology in skin inflammation. Semin Immunopathol 2019; 41:359-77.
Shu HB, Takeuchi M, Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996; 93:13973-8.
Gon S, Gatanaga T, Sendo F. Involvement of two types of TNF receptor in TNF-α induced neutrophil apoptosis. Microbiol Immunol 1996; 40:463-5.
Gabl M, Sundqvist M, Holdfeldt A et al. Mitocryptides from human mitochondrial DNA-encoded proteins activate neutrophil formyl peptide receptors: receptor preference and signaling properties. J Immunol 2018; 200:3269-82.
Osei-Owusu P, Charlton TM, Kim HK et al. FPR1 is the plague receptor on host immune cells. Nature 2019; 574:57-62.
Sina C, Gavrilova O, Förster M et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol 2009; 183:7514-22.
Chamuleau ME, Ossenkoppele GJ, van Rhenen A et al. High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2. Leuk Res 2011; 35:741-9.
Dąbrowska D, Jabłońska E, Iwaniuk A, Garley M. Many ways - one destination: different types of neutrophils death. Int Rev Immunol 2019; 38:18-32.
Hsieh SL, Lin WW. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. J Biomed Sci 2017; 24:39.
Yang H, Jiang H, Song Y et al. Neutrophil CD16b crosslinking induces lipid raft-mediated activation of SHP-2 and affects cytokine expression and retarded neutrophil apoptosis. Exp Cell Res 2018; 362:121-31.
Miyajima A. Molecular structure of the IL-3, GM-CSF and IL-5 receptors. Int J Cell Cloning 1992; 10:126-34.
Wright HL, Thomas HB, Moots RJ, Edwards SW. RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. PLoS One 2013; 8:e58598.
Bonsignore P, Kuiper JWP, Adrian J et al. CEACAM3-A Prim(at)e invention for opsonin-independent phagocytosis of bacteria. Front Immunol 2019; 10:3160.
Rohwedder I, Kurz ARM, Pruenster M et al. Src family kinase-mediated vesicle trafficking is critical for neutrophil basement membrane penetration. Haematologica 2020; 105:1845-56.
Lőrincz AM, Szeifert V, Bartos B et al. Different calcium and Src family kinase signaling in Mac-1 dependent phagocytosis and extracellular vesicle generation. Front Immunol 2019; 10:2942.
Cárdenas ML, Cornish-Bowden A, Ureta T. Evolution and regulatory role of the hexokinases. Biochim Biophys Acta 1998; 1401:242-64.
Rattan R, Narita K, Chien J et al. TCEAL7, a putative tumor suppressor gene, negatively regulates NF-κB pathway. Oncogene 2010; 29:1362-73.
Gómez-Gaviro M, Dominguez-Luis M, Canchado J et al. Expression and regulation of the metalloproteinase ADAM-8 during human neutrophil pathophysiological activation and its catalytic activity on L-selectin shedding. J Immunol 2007; 178:8053-63.
Schlomann U, Koller G, Conrad C et al. ADAM8 as a drug target in pancreatic cancer. Nat Commun 2015; 6:6175.
Zack MD, Malfait AM, Skepner AP et al. ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala(271). Arthritis Rheum 2009; 60:2704-13.
Dreymueller D, Pruessmeyer J, Schumacher J et al. The metalloproteinase ADAM8 promotes leukocyte recruitment in vitro and in acute lung inflammation. Am J Physiol Lung Cell Mol Physiol 2017; 313:L602-L614.
Ong CW, Elkington PT, Brilha S et al. Neutrophil-derived MMP-8 drives AMPK-dependent matrix destruction in human pulmonary tuberculosis. PLOS Pathog 2015; 11:e1004917.
Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 2013; 13:649-65.
Nie J, Pei D. Rapid inactivation of alpha-1-proteinase inhibitor by neutrophil specific leukolysin/membrane-type matrix metalloproteinase 6. Exp Cell Res 2004; 296:145-50.
Radichev IA, Remacle AG, Shiryaev SA et al. Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase. J Biol Chem 2010; 285:16076-86.
Caraux A, Perez-Andres M, Larroque M et al. Mobilization of plasma cells in healthy individuals treated with granulocyte colony-stimulating factor for haematopoietic stem cell collection. Immunology 2011; 132:266-72.
Gudjonsson JE, Tsoi LC, Ma F et al. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis. JCI Insight 2020; 5:e139930.
Miller IM, Ring HC, Prens EP et al. Leukocyte profile in peripheral blood and neutrophil-lymphocyte ratio in hidradenitis suppurativa: a comparative cross-sectional study of 462 cases. Dermatology 2016; 232:511-9.